Your browser doesn't support javascript.
loading
Projecting future drug expenditures--2005.
Hoffman, James M; Shah, Nilay D; Vermeulen, Lee C; Hunkler, Robert J; Hontz, Karrie M.
Afiliação
  • Hoffman JM; Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, TN, USA.
Am J Health Syst Pharm ; 62(2): 149-67, 2005 Jan 15.
Article em En | MEDLINE | ID: mdl-15700889
ABSTRACT

PURPOSE:

Drug expenditure trends in 2003 and 2004 and projected drug expenditures for 2005 are discussed.

SUMMARY:

Various factors are likely to affect drug costs, including drug prices, drugs in development, and generic drugs. In 2003 there was a continued moderation of the increase in drug expenditures. Drug expenditures increased by 11.4% from 2002 to 2003. Through the first nine months of 2004, expenditures increased by only 8.7% compared with 2003. This moderation can be attributed to many factors, particularly patent expirations, prescription-to-nonprescription conversions and a continued slowdown in new drug approvals. Higher cost sharing for consumers and continued weaknesses in several sectors of the U.S. economy affecting employment levels and insurance coverage also contributed to this smaller increase in drug utilization. It is expected that 2005 drug expenditure growth will out-pace the growth in overall health care expenditures and growth in the economy.

CONCLUSION:

In 2005, there should be a 10-12% increase in drug expenditures in outpatient settings, a 12-15% increase in clinics, and a 6-9% increase in hospitals.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Previsões Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Previsões Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article